The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India

In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a mole...

Full description

Bibliographic Details
Main Authors:	Duggan, Mark, Garthwaite, Craig, Goyal, Aparajita
Format:	Journal Article
Language:	en_US
Published:	American Economic Association 2016
Subjects:	intellectual property patents pharmaceutical industry World Trade Organization TRIPS
Online Access:	http://hdl.handle.net/10986/23939

id	okr-10986-23939
recordtype	oai_dc
spelling	okr-10986-239392021-05-25T10:54:43Z The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India Duggan, Mark Garthwaite, Craig Goyal, Aparajita intellectual property patents pharmaceutical industry World Trade Organization TRIPS In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent, with larger increases for more recently developed molecules and for those produced by just one firm when the patent system began. Our results also show little impact on quantities sold or on the number of pharmaceutical firms operating in the market. 2016-03-10T22:40:43Z 2016-03-10T22:40:43Z 2016-01 Journal Article American Economic Review 0002-8282 http://hdl.handle.net/10986/23939 en_US CC BY-NC-ND 3.0 IGO http://creativecommons.org/licenses/by-nc-nd/3.0/igo American Economic Association American Economic Association Publications & Research :: Journal Article Publications & Research South Asia India
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	en_US
topic	intellectual property patents pharmaceutical industry World Trade Organization TRIPS
spellingShingle	intellectual property patents pharmaceutical industry World Trade Organization TRIPS Duggan, Mark Garthwaite, Craig Goyal, Aparajita The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India
geographic_facet	South Asia India
description	In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent, with larger increases for more recently developed molecules and for those produced by just one firm when the patent system began. Our results also show little impact on quantities sold or on the number of pharmaceutical firms operating in the market.
format	Journal Article
author	Duggan, Mark Garthwaite, Craig Goyal, Aparajita
author_facet	Duggan, Mark Garthwaite, Craig Goyal, Aparajita
author_sort	Duggan, Mark
title	The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India
title_short	The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India
title_full	The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India
title_fullStr	The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India
title_full_unstemmed	The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India
title_sort	market impacts of pharmaceutical product patents in developing countries : evidence from india
publisher	American Economic Association
publishDate	2016
url	http://hdl.handle.net/10986/23939
_version_	1764455219798736896

The Market Impacts of Pharmaceutical Product Patents in Developing Countries : Evidence from India

Similar Items